Compare MEDINOVA DIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MEDINOVA DIAG. vs KIMS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MEDINOVA DIAG. KIMS MEDINOVA DIAG./
KIMS
 
P/E (TTM) x 11.8 - - View Chart
P/BV x - 12.3 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 MEDINOVA DIAG.   KIMS
EQUITY SHARE DATA
    MEDINOVA DIAG.
Mar-21
KIMS
Mar-21
MEDINOVA DIAG./
KIMS
5-Yr Chart
Click to enlarge
High Rs31NA-   
Low Rs11NA-   
Sales per share (Unadj.) Rs12.8171.4 7.4%  
Earnings per share (Unadj.) Rs1.926.5 7.2%  
Cash flow per share (Unadj.) Rs2.635.4 7.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %0NM- 
Book value per share (Unadj.) Rs-7.2111.3 -6.5%  
Shares outstanding (eoy) m9.9877.59 12.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.70-   
Avg P/E ratio x11.10-  
P/CF ratio (eoy) x8.10-  
Price / Book Value ratio x-2.90-  
Dividend payout %00-   
Avg Mkt Cap Rs m2110-   
No. of employees `000NANA-   
Total wages/salary Rs m172,202 0.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12713,299 1.0%  
Other income Rs m1102 1.3%   
Total revenues Rs m12913,401 1.0%   
Gross profit Rs m303,757 0.8%  
Depreciation Rs m7695 1.0%   
Interest Rs m5373 1.2%   
Profit before tax Rs m202,790 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1735 0.1%   
Profit after tax Rs m192,055 0.9%  
Gross profit margin %23.628.3 83.5%  
Effective tax rate %2.926.4 11.1%   
Net profit margin %14.915.5 96.7%  
BALANCE SHEET DATA
Current assets Rs m164,512 0.3%   
Current liabilities Rs m802,783 2.9%   
Net working cap to sales %-50.213.0 -386.3%  
Current ratio x0.21.6 12.0%  
Inventory Days Days1911 163.6%  
Debtors Days Days18830 624.2%  
Net fixed assets Rs m259,820 0.3%   
Share capital Rs m100776 12.8%   
"Free" reserves Rs m-1727,861 -2.2%   
Net worth Rs m-728,637 -0.8%   
Long term debt Rs m331,846 1.8%   
Total assets Rs m4114,332 0.3%  
Interest coverage x5.28.5 61.8%   
Debt to equity ratio x-0.50.2 -212.9%  
Sales to assets ratio x3.10.9 336.7%   
Return on assets %58.016.9 342.6%  
Return on equity %-26.523.8 -111.2%  
Return on capital %-61.830.2 -204.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m193,560 0.5%  
From Investments Rs m-3-3,542 0.1%  
From Financial Activity Rs m-1498 -14.0%  
Net Cashflow Rs m2116 2.1%  

Share Holding

Indian Promoters % 62.1 38.8 160.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 28.5 -  
FIIs % 0.0 9.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 37.9 61.2 61.9%  
Shareholders   9,804 86,389 11.3%  
Pledged promoter(s) holding % 0.0 13.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MEDINOVA DIAG. With:   SONI MEDICARE  NIDAN LABORATORIES AND HEALTHCARE  KRSNAA DIAGNOSTICS  TRANSGENE BI  NARAYANA HRUDAYALAYA  



Today's Market

SGX Nifty Up 114 Points, FabIndia IPO, Tanla Platforms' Partnership with Vodafone Idea, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Benchmark indices snapped two days of losses and witnessed sharp gains as globally fears of a significant impact on economic.

Related Views on News

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

From Paytm to Reliance Power: Big IPOs with the Worst Debut Day Performance (Views On News)

Nov 22, 2021

Paytm's flop show should not come as a surprise. This is not the first time a high-profile IPO has eroded investors' wealth on listing day.

Top 5 Stocks in which FIIs Sequentially Raised their Stakes (Views On News)

Oct 26, 2021

FIIs have largely stayed on the sidelines this month, booking profits at every opportunity they get, amid tapering concerns.

India's New Drone Scheme: Watch Out for these Stocks (Views On News)

Oct 1, 2021

New drone rules and the PLI scheme is a huge confidence booster for startups and MSMEs. It will open new opportunities for drone companies.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MEDINOVA DIAG. SHARE PRICE


Dec 7, 2021 (Close)

TRACK MEDINOVA DIAG.

  • Track your investment in MEDINOVA DIAG. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MEDINOVA DIAG.

MEDINOVA DIAG. - KRSNAA DIAGNOSTICS COMPARISON

COMPARE MEDINOVA DIAG. WITH

MARKET STATS